Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4864) 4864
Publication (585) 585
Book Review (192) 192
Book Chapter (31) 31
Newsletter (19) 19
Conference Proceeding (18) 18
Magazine Article (14) 14
Book / eBook (8) 8
Newspaper Article (5) 5
Dissertation (4) 4
Data Set (2) 2
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2706) 2706
capsaicin (2632) 2632
male (2203) 2203
index medicus (2186) 2186
humans (2177) 2177
capsaicin - pharmacology (1424) 1424
pharmacology & pharmacy (1387) 1387
rats (1369) 1369
pain (1142) 1142
female (1127) 1127
neurosciences (929) 929
mice (825) 825
capsaicin - therapeutic use (691) 691
rats, sprague-dawley (617) 617
adult (613) 613
dose-response relationship, drug (563) 563
capsaicin receptor (540) 540
sensory neurons (513) 513
trpv1 (508) 508
middle aged (507) 507
inflammation (504) 504
trpv cation channels - metabolism (495) 495
capsaicin - administration & dosage (487) 487
neurons (486) 486
clinical neurology (440) 440
pain - drug therapy (435) 435
neuropathic pain (417) 417
analysis (410) 410
rats, wistar (407) 407
disease models, animal (399) 399
activation (397) 397
substance-p (397) 397
rat (388) 388
capsaicin - analogs & derivatives (387) 387
capsaicin receptors (387) 387
care and treatment (373) 373
gene-related peptide (359) 359
rodents (353) 353
double-blind (339) 339
research (328) 328
aged (322) 322
analgesics - therapeutic use (308) 308
physiology (301) 301
anesthesiology (300) 300
phenols (299) 299
mechanisms (296) 296
trpv cation channels - antagonists & inhibitors (288) 288
hyperalgesia (286) 286
biochemistry & molecular biology (275) 275
article (273) 273
time factors (261) 261
double-blind method (258) 258
expression (257) 257
physiological aspects (256) 256
analgesics (254) 254
health aspects (252) 252
treatment outcome (252) 252
pharmacology (249) 249
nervous system (248) 248
medicine (247) 247
pain measurement (246) 246
topical capsaicin (245) 245
analgesics - pharmacology (233) 233
guinea pigs (231) 231
receptor (229) 229
research article (229) 229
receptors (228) 228
cells, cultured (227) 227
in vitro techniques (227) 227
transient receptor potential proteins (219) 219
multidisciplinary sciences (217) 217
administration, topical (216) 216
pain perception (215) 215
neurons, afferent - drug effects (214) 214
substance p (213) 213
pain - physiopathology (210) 210
cell biology (206) 206
mice, inbred c57bl (205) 205
skin (200) 200
hyperalgesia - drug therapy (198) 198
lipids (198) 198
vanilloid receptor (194) 194
pain - chemically induced (193) 193
chemistry, medicinal (189) 189
nociception (188) 188
resiniferatoxin (188) 188
spinal-cord (185) 185
in-vitro (183) 183
apoptosis (180) 180
inhibition (180) 180
proteins (178) 178
neuralgia - drug therapy (177) 177
trpv cation channels - genetics (175) 175
ion channels (174) 174
capsaicin - adverse effects (172) 172
science (172) 172
calcium - metabolism (169) 169
calcitonin gene-related peptide (168) 168
calcium (168) 168
cancer (166) 166
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4838) 4838
German (30) 30
French (21) 21
Japanese (12) 12
Spanish (7) 7
Chinese (6) 6
Italian (6) 6
Hungarian (4) 4
Russian (4) 4
Korean (2) 2
Polish (2) 2
Hebrew (1) 1
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Therapeutic use of botulinum toxin in migraine: mechanisms of action
by Ramachandran, Roshni and Yaksh, Tony L
British Journal of Pharmacology, ISSN 0007-1188, 09/2014, Volume 171, Issue 18, pp. 4177 - 4192
Migraine pain represents sensations arising from the activation of trigeminal afferents, which innervate the meningeal vasculature and project to the... 
DURA-MATER-ENCEPHALI | NEUROPATHIC PAIN | GENE-RELATED PEPTIDE | AMPA RECEPTOR TRAFFICKING | PREEMPT CLINICAL-PROGRAM | STEM TRIGEMINAL NEURONS | CAPSAICIN-EVOKED PAIN | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | NEUROTOXIN TYPE-A | PLACEBO-CONTROLLED PHASE | Botulinum Toxins - therapeutic use | Botulinum Toxins - pharmacology | Animals | Pain - drug therapy | Humans | Neurons, Afferent - metabolism | Pain - metabolism | Migraine Disorders - drug therapy | SNARE Proteins - metabolism | Migraine Disorders - metabolism | Health aspects | Migraine | Botulism | Pain | Reviews
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text EULAR revised recommendations for the management of fibromyalgia
by Macfarlane, G J and Kronisch, C and Dean, L E and Atzeni, F and Häuser, W and Fluß, E and Choy, E and Kosek, E and Amris, K and Branco, J and Dincer, F and Leino-Arjas, P and Longley, K and McCarthy, G M and Makri, S and Perrot, S and Sarzi-Puttini, P and Taylor, A and Jones, G T
Annals of the Rheumatic Diseases, ISSN 0003-4967, 02/2017, Volume 76, Issue 2, pp. 318 - 328
ObjectiveThe original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant... 
CLINICAL-PRACTICE GUIDELINES | RANDOMIZED CONTROLLED-TRIALS | COGNITIVE-BEHAVIORAL THERAPIES | MIND-BODY THERAPIES | COMPARATIVE EFFICACY | CHRONIC PAIN | AEROBIC EXERCISE | RHEUMATOLOGY | NONPHARMACOLOGICAL INTERVENTIONS | STRESS REDUCTION | PHARMACOLOGICAL-TREATMENTS | Fibromyalgia - therapy | Capsaicin - therapeutic use | Humans | Cognitive Behavioral Therapy | Acupuncture Therapy | Exercise Therapy | Activities of Daily Living | Human Growth Hormone - therapeutic use | Societies, Medical | Fatigue - therapy | Amitriptyline - analogs & derivatives | Mind-Body Therapies | Sensory System Agents - therapeutic use | Manipulation, Chiropractic | Monoamine Oxidase Inhibitors - therapeutic use | Europe | Serotonin Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Biofeedback, Psychology | Treatment Outcome | Evidence-Based Medicine | Mindfulness | Hydrotherapy | Sleep | Antidepressive Agents, Tricyclic - therapeutic use | S-Adenosylmethionine - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pain - physiopathology | Fatigue - physiopathology | Amitriptyline - therapeutic use | Hypnosis | Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use | Massage | Fibromyalgia - physiopathology | Sodium Oxybate - therapeutic use | Practice Guidelines as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Treating Painful Diabetic Peripheral Neuropathy: An Update
by Snyder, Matthew J., DO and Gibbs, Lawrence M., MD and Lindsay, Tammy J., MD
American Family Physician, ISSN 0002-838X, 2016, Volume 94, Issue 3, pp. 227 - 234
Painful diabetic peripheral neuropathy occurs in approximately 25% of patients with diabetes mellitus who are treated in the office setting and significantly... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | POLYNEUROPATHY | DULOXETINE | PREGABALIN | EFFICACY | NERVE-STIMULATION | OPEN-LABEL | PRIMARY HEALTH CARE | EXTENDED-RELEASE | RANDOMIZED-WITHDRAWAL | GUIDELINE | VENLAFAXINE | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Transcutaneous Electric Nerve Stimulation | Duloxetine Hydrochloride - therapeutic use | Pregabalin - therapeutic use | Vasodilator Agents - therapeutic use | Capsaicin - therapeutic use | Humans | Serotonin Uptake Inhibitors - therapeutic use | Analgesics, Opioid - therapeutic use | Lidocaine - therapeutic use | Venlafaxine Hydrochloride - therapeutic use | Tramadol - therapeutic use | Diabetic Neuropathies - therapy | Phenols - therapeutic use | Serotonin and Noradrenaline Reuptake Inhibitors | Amines - therapeutic use | Amitriptyline - therapeutic use | Anesthetics, Local - therapeutic use | gamma-Aminobutyric Acid - therapeutic use | Isosorbide Dinitrate - therapeutic use | Sensory System Agents - therapeutic use | Administration, Topical | Complications and side effects | Polyneuropathies | Tramadol | Dosage and administration | Diabetes | Pregabalin | Drug therapy | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
by Dworkin, Robert H., PhD and O'Connor, Alec B., MD and Audette, Joseph, MD and Baron, Ralf, Dr Med and Gourlay, Geoffrey K., PhD and Haanpää, Maija L., MD, PhD and Kent, Joel L., MD and Krane, Elliot J., MD and LeBel, Alyssa A., MD and Levy, Robert M., MD, PhD and Mackey, Sean C., MD, PhD and Mayer, John, DC, PhD and Miaskowski, Christine, RN, PhD and Raja, Srinivasa N., MD and Rice, Andrew S.C., MB, MD, FRCA and Schmader, Kenneth E., MD and Stacey, Brett, MD and Stanos, Steven, DO and Treede, Rolf-Detlef, Dr Med and Turk, Dennis C., PhD and Walco, Gary A., PhD and Wells, Christopher D., MB
Mayo Clinic Proceedings, ISSN 0025-6196, 2010, Volume 85, Issue 3, pp. S3 - S14
The Neuropathic Pain Special Interest Group of the International Association for the Study of Pain recently sponsored the development of evidence-based... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CONCENTRATION CAPSAICIN PATCH | POSTHERPETIC NEURALGIA | CLINICAL-TRIALS | DIABETIC PERIPHERAL NEUROPATHY | DOUBLE-BLIND | SPINAL-CORD-INJURY | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | LIDOCAINE MEDICATED PLASTER | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Humans | Serotonin Uptake Inhibitors - therapeutic use | Analgesics, Opioid - therapeutic use | Pregabalin | Evidence-Based Medicine | Neuralgia - drug therapy | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Acetamides - therapeutic use | Neuralgia - prevention & control | Amines - therapeutic use | Anesthetics, Local - therapeutic use | gamma-Aminobutyric Acid - therapeutic use | gamma-Aminobutyric Acid - analogs & derivatives | Practice Guidelines as Topic | Calcium channels | Care and treatment | Gabapentin | Research | Properties | Evidence-based medicine | Peripheral nerve diseases | Pain | Opioids | Dosage and administration | Diagnosis | Methods | Cancer | Supplement
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch
by Anand, P and Bley, K
British Journal of Anaesthesia, ISSN 0007-0912, 10/2011, Volume 107, Issue 4, pp. 490 - 502
Topical capsaicin formulations are used for pain management. Safety and modest efficacy of low-concentration capsaicin formulations, which require repeated... 
nociceptor | neuropathic pain | TRPV1 | nerve growth factor | capsaicin | Capsaicin | CONTROLLED-TRIAL | ROOT GANGLION NEURONS | RECEPTOR TRPV1 | NERVE GROWTH-FACTOR | INSENSITIVE NOCICEPTORS | POSTHERPETIC NEURALGIA | DOUBLE-BLIND | INTRANASAL CAPSAICIN | CAPSICUM-FRUTESCENS | ANESTHESIOLOGY | SMALL-FIBER NEUROPATHY | Analgesics - pharmacology | Analgesics - therapeutic use | Capsaicin - pharmacology | Capsaicin - therapeutic use | Humans | Capsaicin - adverse effects | Analgesics - administration & dosage | Analgesics - pharmacokinetics | Capsaicin - administration & dosage | Hyperalgesia - physiopathology | Animals | Hyperalgesia - drug therapy | Pain - drug therapy | Administration, Topical | Nociceptors - drug effects | Analgesics - adverse effects | Capsaicin - pharmacokinetics | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
by Attal, N and Cruccu, G and Baron, R and Haanpää, M and Hansson, P and Jensen, T. S and Nurmikko, T and European Federation of Neurological Societies
European Journal of Neurology, ISSN 1351-5101, 09/2010, Volume 17, Issue 9, pp. 1113 - e88
Background and objectives:  This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the... 
central neuropathic pain | neuropathic pain | pharmacological treatment | trigeminal neuralgia | randomized clinical trials | painful diabetic polyneuropathy | post‐herpetic neuralgia | evidence‐based recommendations | evidence-based recommendations | post-herpetic neuralgia | RANDOMIZED CONTROLLED-TRIALS | CONCENTRATION CAPSAICIN PATCH | POSTHERPETIC NEURALGIA PATIENTS | NEUROSCIENCES | CLINICAL NEUROLOGY | CONTROLLED CLINICAL-TRIAL | DIABETIC PERIPHERAL NEUROPATHY | DOUBLE-BLIND | SPINAL-CORD-INJURY | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Europe | Humans | Analgesics, Opioid - therapeutic use | Treatment Outcome | Neuralgia - drug therapy | Drug Therapy, Combination - trends | Antidepressive Agents, Tricyclic - therapeutic use | Amines - therapeutic use | Analgesia - trends | Outcome Assessment (Health Care) - trends | Peripheral Nervous System Diseases - classification | gamma-Aminobutyric Acid - therapeutic use | Neuralgia - classification | Randomized Controlled Trials as Topic - trends | Peripheral Nervous System Diseases - drug therapy | Care and treatment | Online health care information services | Neurosciences | Task forces | Pain | Gabapentin | Comorbidity | Practice guidelines (Medicine) | Universities and colleges | Antidepressants, Tricyclic | Narcotics | Antidepressants | Pain management
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition
by Harden, R and Oaklander, A.L and Burton, A.W and Perez, R.S.G.M and Richardson, K and Swan, M and Barthel, J and Costa, B and Graciosa, J.R and Bruehl, S and Reflex Sympathetic Dystrophy Syndrome Association
Pain Medicine, ISSN 1526-2375, 2013, Volume 14, Issue 2, pp. 180 - 229
Objective: This is the fourth edition of diagnostic and treatment guidelines for complex regional pain syndrome (CRPS; aka reflex sympathetic dystrophy).... 
Therapy | Diagnosis | Complex Regional Pain Syndrome | Reflex Sympathetic Dystrophy | Guidelines | RANDOMIZED CONTROLLED-TRIALS | LOW-BACK-PAIN | CONCENTRATION CAPSAICIN PATCH | ADJUVANT PHYSICAL-THERAPY | RECEPTOR ANTAGONIST KETAMINE | FACILITATED NEUROGENIC INFLAMMATION | STELLATE GANGLION BLOCK | MEDICINE, GENERAL & INTERNAL | SYNDROME TYPE-I | SPINAL-CORD STIMULATION | ANESTHESIOLOGY | Occupational Therapy | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Reflex Sympathetic Dystrophy - diagnosis | Reflex Sympathetic Dystrophy - rehabilitation | Complex Regional Pain Syndromes - rehabilitation | Humans | Reflex Sympathetic Dystrophy - drug therapy | Recreation Therapy | Anticonvulsants - therapeutic use | Bone Density Conservation Agents - therapeutic use | Analgesics, Opioid - therapeutic use | Complex Regional Pain Syndromes - diagnosis | Adrenergic alpha-Agonists - therapeutic use | Rehabilitation, Vocational | Antidepressive Agents, Tricyclic - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Physical Therapy Modalities | Anesthetics, Local - therapeutic use | Complex Regional Pain Syndromes - drug therapy | Practice guidelines (Medicine) | Care and treatment | Pain
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights